The National Agency for Food and Drug Administration and Control (NAFDAC), on Friday, 20th March, approved the production of Chloroquine for clinical trials in the search for a cure for Coronavirus, simply known as COVID-19.
Mojisola Adeyeye Director-General of the agency made the announcement on Friday, at the headquarters in Lagos.
The DG said that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.”
“Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.
She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of the clinical trial,” she concluded.
Ye, formerly known as Kanye West, appears to have confirmed reports that he's set to launch an adult entertainment site.…
In the bustling heart of Lagos, 58-year-old Emeka Joshua, a retired teacher, stands at the counter of a local pharmacy.…
Can Kids Drink Poppi, Olipop, & Other Prebiotic Sodas? Green powders, gummy vitamins for every aspect of our health, and…
Is it true that drinking soy milk can make a man’s breasts to enlarge or grow bigger? The idea is…
A Cardiologist, Dr Kayode Atoyebi, has said that listening to music at bedtime is important and beneficial to the heart.…
China Aerospace Science and Technology Corp, the country's major space contractor, conducted on Sunday a major test on a new…